Name: Genomics England
Address: Queen Mary University of London, Dawson Hall, Charterhouse Square, London, London, EC1M 6BQ, UK
Telephone: 0808 2819 535
Price range: $

Researchers uncover a key driver of aggressive bone cancer
By Florence Cornish on 12 Feb 2025

New research using data from the 100,000 Genomes Project has identified a genetic change that drives osteosarcoma, an aggressive childhood bone cancer.
Cancer

Research
Genetic testing could lower the risk of adverse drug reactions for thousands of patients with cancer
By Florence Cornish on 4 Nov 2024

A recent study found that around 14,000 patients with cancer could have reduced risk of harmful side effects from cancer treatment by receiving a lower dose or a different drug.
Cancer

Research

Clinical care
Whole genome sequencing reveals cause of rare eye condition in South Asian and African communities
By Ayan Younis on 27 Sep 2024

A recent study by Samantha Malka and colleagues used data from the 100,000 Genomes Project to find genetic causes of a rare eye condition in South Asian and African communities.
Research

Rare disease

Diverse Data
Genetic map of colorectal cancer reveals potential targets for treatment
By Florence Cornish on 7 Aug 2024

Researchers have performed the largest genetic analysis of colorectal cancer to date, identifying new driver genes and potential drug targets for treatment.
Research
Whole genome sequencing finds common cause of neurodevelopmental disorders
By Florence Cornish on 2 Aug 2024

Recent research has discovered a common cause for neurodevelopmental disorders in the non-coding genome, providing a diagnosis to hundreds of people around the world and potentially thousands more.
Research

Rare disease
Whole genome sequencing can improve childhood cancer care
By Florence Cornish on 16 Jul 2024

Whole genome sequencing could improve our ability to detect and treat childhood cancers. New research investigates the real-time impact of routine whole genome sequencing for cancer in the NHS.
Cancer

Research

Blog

Latest

Researchers uncover a key driver of aggressive bone cancer

Genetic testing could lower the risk of adverse drug reactions for thousands of patients with cancer

Whole genome sequencing reveals cause of rare eye condition in South Asian and African communities

Genetic map of colorectal cancer reveals potential targets for treatment

Whole genome sequencing finds common cause of neurodevelopmental disorders

Whole genome sequencing can improve childhood cancer care

Media contact

Follow us

Explore Genomics England

Latest

Researchers uncover a key driver of aggressive bone cancer

Genetic testing could lower the risk of adverse drug reactions for thousands of patients with cancer

Whole genome sequencing reveals cause of rare eye condition in South Asian and African communities

Genetic map of colorectal cancer reveals potential targets for treatment

Whole genome sequencing finds common cause of neurodevelopmental disorders

Whole genome sequencing can improve childhood cancer care

Media contact

Follow us

Get the latest updates straight to your inbox

Explore Genomics England